Andrés Cubillos-Ruiz

Andrés Cubillos-Ruiz, PhD is the co-founder and Chief Executive Officer of Florey Biosciences. He is a microbiologist with expertise in microbial evolution and bioengineering. Andrés received his PhD from the Massachusetts Institute of Technology and completed postdoctoral studies at the Institute for Medical Science and Engineering at MIT. In 2020, he joined the Wyss Institute for Biologically Inspired Engineering at Harvard, where he worked on advancing both the technical and commercial aspects of a platform for delivering biological effectors to the human gut using microbes. The platform's first application, an engineered probiotic designed to manage the harmful effects of antibiotics on the gut microbiome, became the foundation for Florey Biosciences.